about
Potential for bispecific T-cell engagers: role of blinatumomab in acute lymphoblastic leukemiaNovel cancer antigens for personalized immunotherapies: latest evidence and clinical potentialZebrafish Models of Human Leukemia: Technological Advances and Mechanistic InsightsAntibody-siRNA conjugates: drugging the undruggable for anti-leukemic therapy.Profile of blinatumomab and its potential in the treatment of relapsed/refractory acute lymphoblastic leukemia.The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.Effective elimination of adult B-lineage acute lymphoblastic leukemia by disulfiram/copper complex in vitro and in vivo in patient-derived xenograft models.Defective quorum sensing of acute lymphoblastic leukemic cells: evidence of collective behavior of leukemic populations as semi-autonomous aberrant ecosystems.Muramyl dipeptide and anti-CD10 monoclonal antibody immunoconjugate enhances anti-leukemia immunity of T lymphocytes.Prognostic impact of incomplete hematologic count recovery and minimal residual disease on outcome in adult acute lymphoblastic leukemia at the time of second complete response.
P2860
Q26764903-96B9935B-AAA7-4172-9F2B-71E404BD385AQ26769884-F82D2B92-2863-4A80-B8A0-0C4B940509D4Q28078210-AD86D6D7-0EDA-4737-AC4B-906FC1761400Q30275229-EFA8488B-B0EE-4F04-8B64-1BA8E5AC1E99Q35799427-C55E61D8-102B-408E-8B8C-DA6B63136321Q37517482-96C48692-B86B-49A3-8D33-C45919173884Q37696104-B2BD1F9C-CD5B-457E-81F0-5DE62F729C4AQ38757530-0B9BAAD2-8EC3-4D69-82D2-4F9B7E79130DQ39680289-FF5CB3B7-187D-4DCB-9F75-A6A44AF25678Q50537925-3BA8B84F-C030-4EF5-96EF-C4FDEC876944
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Current status of antibody therapy in ALL.
@en
type
label
Current status of antibody therapy in ALL.
@en
prefLabel
Current status of antibody therapy in ALL.
@en
P2860
P356
P1476
Current status of antibody therapy in ALL.
@en
P2093
Anjali Advani
P2860
P304
P356
10.1111/BJH.13205
P407
P577
2014-11-10T00:00:00Z